Treatment Considerations in T2D
ACC 2022: An Overview of SGLT2i and GLP1 RA Use in Cardiovascular Disease
By
ACC 2022 Conference Coverage
FEATURING
Robert Eckel
By
ACC 2022 Conference Coverage
FEATURING
Robert Eckel
Login to view comments.
Click here to Login